Wrist Arthroscopy Study
Primary Purpose
Wrist Arthropathy
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Diagnostic Arthroscopy using the Arthrex NanoScope
Diagnostic Arthroscopy using standard arthroscopic instruments
Sponsored by
About this trial
This is an interventional diagnostic trial for Wrist Arthropathy
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years.
- Wrist pathology based on clinical examination/imaging studies undergoing wrist arthroscopy for further evaluation/treatment.
- Willingness to participate in the study
Exclusion Criteria:
- 1. Age < 18 years.
Sites / Locations
- NYU Langone Health
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Experimental Cohort
Arm Description
Patients with clinically diagnosed wrist pathology undergoing wrist arthroscopy
Outcomes
Primary Outcome Measures
Diagnostic accuracy (%) of Arthrex Nanoscope
Diagnostic accuracy of the Arthrex Nanoscope will be described as a incidence/percentage compared to the diagnosis determined by wrist arthroscopy with conventional instruments.
Secondary Outcome Measures
Incidence of change in intervention
Incidence of changes between "intended" treatment and "final" treatment.
"Surgeon-rated ease of use of Arthrex NanoScope "
Ease of use will be rated on a 5-point scale: (1) - very difficult; (2) - difficult; (3) - netural; (4) - easy; (5) - very easy.
Surgeon-rated confidence in Arthrex NanoScope diagnosis
Confidence will be rated on a 5-point scale: (1) - not at all confident; (2) - not very confident; (3) - netural; (4) - fairly confident; (5) - very confident.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04457362
Brief Title
Wrist Arthroscopy Study
Official Title
A Comparative Study Evaluating the Diagnostic Accuracy of Wrist Arthroscopy Using the NanoScope Compared to Conventional Arthroscopic Instrumentation
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
October 10, 2020 (Actual)
Primary Completion Date
March 22, 2023 (Actual)
Study Completion Date
March 22, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate the diagnostic efficacy of Arthrex NanoScope compared to conventional arthroscopic instruments. Patients with wrist pathology who are indicated for an arthroscopic procedure will be enrolled pre-operatively after a thorough discussion of the study aims, risks, and benefits. At the time of surgery, under standard conditions, using standard wrist arthroscopy portals, a diagnostic arthroscopy will be performed with the Arthrex Nanoscope. The diagnostic arthroscopy will be performed in a stepwise manner for consistency with notation of pathology and intended intervention. The diagnostic arthroscopy will then be performed with the standard arthroscopic equipment, again noting pathology and final intervention. Post-operatively, diagnostic accuracy, incidence of change in intervention, and surgeon rated ease of use and confidence will be determined.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wrist Arthropathy
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Prospective Cohort Study, Diagnostic
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental Cohort
Arm Type
Experimental
Arm Description
Patients with clinically diagnosed wrist pathology undergoing wrist arthroscopy
Intervention Type
Diagnostic Test
Intervention Name(s)
Diagnostic Arthroscopy using the Arthrex NanoScope
Intervention Description
A diagnostic arthroscopy will be performed with the Arthrex NanoScope.
Structures evaluated:
Radial styloid
Proximal scaphoid articular cartilage
Scaphoid fossa
Radioscaphocapitate (RSC) ligament
Long radiolunate (LRL) ligament
Short radiolunate (SRL) ligament
Scapholunate (SL) ligament
Proximal lunate articular cartilage
Lunate fossa
Triangular fibrocartilage complex (TFCC) The attending performing the diagnostic arthroscopy will make an initial diagnostic assessment based on the presence/location/severity of synovitis, articular cartilage integrity, ligament injury and determine the intended treatment.
Intervention Type
Diagnostic Test
Intervention Name(s)
Diagnostic Arthroscopy using standard arthroscopic instruments
Intervention Description
A diagnostic arthroscopy will be performed with the standard arthroscopic instruments.
Structures evaluated:
Radial styloid
Proximal scaphoid articular cartilage
Scaphoid fossa
Radioscaphocapitate (RSC) ligament
Long radiolunate (LRL) ligament
Short radiolunate (SRL) ligament
Scapholunate (SL) ligament
Proximal lunate articular cartilage
Lunate fossa
Triangular fibrocartilage complex (TFCC) The attending performing the diagnostic arthroscopy will make the final diagnostic assessment based on the presence/location/severity of synovitis, articular cartilage integrity, and ligament injury and determine the final treatment.
Primary Outcome Measure Information:
Title
Diagnostic accuracy (%) of Arthrex Nanoscope
Description
Diagnostic accuracy of the Arthrex Nanoscope will be described as a incidence/percentage compared to the diagnosis determined by wrist arthroscopy with conventional instruments.
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Incidence of change in intervention
Description
Incidence of changes between "intended" treatment and "final" treatment.
Time Frame
Day 1
Title
"Surgeon-rated ease of use of Arthrex NanoScope "
Description
Ease of use will be rated on a 5-point scale: (1) - very difficult; (2) - difficult; (3) - netural; (4) - easy; (5) - very easy.
Time Frame
Day 1
Title
Surgeon-rated confidence in Arthrex NanoScope diagnosis
Description
Confidence will be rated on a 5-point scale: (1) - not at all confident; (2) - not very confident; (3) - netural; (4) - fairly confident; (5) - very confident.
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 18 years.
Wrist pathology based on clinical examination/imaging studies undergoing wrist arthroscopy for further evaluation/treatment.
Willingness to participate in the study
Exclusion Criteria:
1. Age < 18 years.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nader Paksima
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: [contact information for PI or designee]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.
IPD Sharing Time Frame
beginning 9 months and ending 36 months following article publication
IPD Sharing Access Criteria
Requests should be directed to ali.azad@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Learn more about this trial
Wrist Arthroscopy Study
We'll reach out to this number within 24 hrs